Increasingly common in daily practice, this is the first guideline update since 2011, aimed to improve success rates and cut complications.

For some patients with atrial fibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) ...

Background Although the prognostic implications of severe mitral regurgitation (MR) are well recognised ... mortality associated with MR severity persisted in the presence of aortic stenosis. To our ...

Abstract: Objective: Ultrasound-based aortic stiffness estimation has the potential to improve the diagnosis and prognosis of patients with abdominal aortic aneurysms (AAA), as a complement to ...

Computed tomography angiography revealed an aorto-caval fistula complicating infrarenal abdominal aortic aneurysm ... bilateral pedal edema, and renal insufficiency (4). Due to the significant ...

The Trilogy valve. [Image from the JenaValve website] GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) this year.

Secondary endpoints were in-hospital mortality, 1-year mortality, bleeding, major vascular complications, myocardial infarction, stroke, incidence of pacemaker implantation, acute kidney injury and ...